If you have keloid scars on your skin, we understand just how frustrating, annoying, and sometimes embarrassing this can be. Keloid scars can be painful and itchy, varying in degrees of sensation from person-to-person, interrupting and causing problems in your daily life. Unfortunately, not even half of the millions of people suffering from keloid scars […]
Blog
Medical device company taps into 1.4 billion-person market with deal in China
Boca Raton medical device maker Sensus Healthcare has been cleared to expand operations in China, bringing its skin-treatment technology to a country with more than 1.4 billion people. Sensus Healthcare (NASDAQ: SRTS) has made a name for itself in the medical community with the SRT-100, a device sold to dermatology practices which non-invasively treats skin conditions, including keloids, […]
Sensus Healthcare Receives Regulatory Approval to Sell the SRT-100™ in China for the Treatment and Prevention of Keloids
BOCA RATON, Fla., July 26, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that the SRT-100™ has been cleared by the China Food and Drug Administration (CFDA) to treat and prevent keloids. China accounts for […]
Sensus Healthcare to Host Second Quarter 2017 Financial Results and Business Update Conference Call on August 3, 2017
BOCA RATON, Fla., July 25, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announces that management will hold a conference call beginning at 4:30 p.m. Eastern Time on Thursday, August 3, 2017 to discuss the financial […]
“I feel more alive:” FOX6 viewers’ generosity helps man get debilitating keloids treated after insurance denial
Treatment with Sensus Healthcare’s SRT-100™ following surgical removal of this man’s keloids reduced the chance of recurrence to just 4%. Click here to view the full article on FOX6NOW.com.
Advancing Keloid Treatment: A Novel Multimodal Approach to Ear Keloids
Michael E. Jones, MD,* Jennifer McLane, FNP,* Rachael Adenegan, FNP-C,* JoAnne Lee, PA-BC,*, and Christine A. Ganzer, PMHNP, PhD† BACKGROUND/OBJECTIVE Management of keloids of the pinna, in particular, those located in the helix and antihelix and lobule that occur as complications of ear piercing. MATERIALS AND METHODS Retrospective analysis of 49 patients treated with extralesional […]
Skin cancer treatment technology provides alternative to surgery for skin cancer patients
Skin cancer generally appears within the first two to three millimeters of the surface of the skin. “The traditional way to treat skin cancer is surgery,” said Dr. Jeffrey Brackeen, with the Skin Cancer Institute of Lubbock. The SRT-100, he said, provides a non-invasive treatment option for skin cancer patients. The tool is relatively new […]
Non-surgical local skin cancer treatment
The National Cancer Institute estimates 40-50% of Americans age 65 and over will have skin cancer at least once. Joe Sardano with Sensus Healthcare stopped by to tell us about its SRT technology the company says provides patients a safe, non-surgical, cosmetically superior alternative that is fast, painless and proven effective. Source: CBS12
The SRT-100™: Non-Invasive Squamous Cell Carcinoma Treatment
While Mohs surgery has proven to be an extremely effective method of treatment for non-melanoma skin cancers like squamous cell carcinoma and basal cell carcinoma, there are many significant downsides to this procedure from a patient’s perspective. Depending on the operation, Mohs surgery can result in large, nasty scarring that requires reconstructive surgery by a […]
The Symptoms of Squamous Cell Carcinoma
The symptoms of squamous cell carcinoma often appear as scaly, irritated skin, or elevated growths similar to warts. Only a trained physician or specialist can decide for sure if it is squamous cell carcinoma. If you believe you may have a squamous cell carcinoma, see a doctor right away. In general, any change in preexisting […]
My New Favorite Thing: SUPERFICIAL RADIATION THERAPY
With Sensus’ superficial radiation therapy (SRT), we may be entering uncharted waters where keloid recurrence after surgery and SRT leads to no, or a very low, incidence of keloid recurrence. With this, we will change the paradigm in the treatment of keloids. The Sensus SRT-100 is a superficial radiation device that has FDA clearance—the first […]
The SRT-100™: Non-Invasive Basal Cell Carcinoma Treatment
While Mohs surgery has proven to be extremely effective at treating non-melanoma skin cancers like basal cell carcinoma and squamous cell carcinoma, there are huge drawbacks to the procedure from the perspective of the patient. Depending on the operation, Mohs surgery can leave behind large, nasty scarring that requires reconstructive surgery by a plastic surgeon. […]
Sensus to Present at the 2017 Marcum MicroCap Conference
BOCA RATON, Fla., June 05, 2017 — Sensus Healthcare, Inc. (Nasdaq:SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), today announced Joe Sardano, the Company’s Chief Executive Officer, will present a corporate overview to investors at the 2017 Marcum MicroCap Conference on Thursday, […]
This Boca Raton company was named South Florida’s most ‘disruptive’
The Greater Miami Chamber of Commerce has named medical device company Sensus Healthcare the most “disruptive” technology startup for 2017. Boca Raton-based Sensus Healthcare specializes in non-invasive tools aimed at treating skin conditions, such as non-melanoma skin cancers. Its best-known device is the SRT-100 Vision, a device sold to dermatologists nationwide. The Technology Leader of […]
Sensus Healthcare Awarded 2017 Technology Leader of the Year for Disruptive Technology from Greater Miami Chamber of Commerce
BOCA RATON, Fla., May 24, 2017 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the treatment of non-melanoma skin cancers (NMSC) and other skin conditions, such as keloids with Superficial Radiotherapy (SRT), has been awarded the 2017 Technology Leader of the Year for the Disruptive Technology category by The Greater Miami […]
The Symptoms of Basal Cell Carcinoma
The symptoms of basal cell carcinoma occasionally resemble the features of non-cancerous skin conditions like psoriasis or eczema. Only a trained physician or specialist can decide for sure if it is basal cell carcinoma. If you believe you may have a basal cell carcinoma, see a doctor right away. The Symptoms of Basal Cell Carcinoma: […]
The Doctor’s Ultimate Wish List for Ending the Skin Cancer Epidemic
Despite tireless public awareness campaigns aimed at encouraging sun-safe behaviors and advances in skin cancer detection, the rates of this all-too-common, but highly preventable cancer continue to rise. Nearly 9,500 Americans are diagnosed with skin cancer each day, and fully one in five Americans will develop skin cancer in their lifetime, according to the American […]
Sensus Healthcare First Quarter Financial Results Feature Revenues up 43%
Sixth consecutive quarter of double-digit year-over-year revenue growth Conference call begins at 4:30 Eastern time today BOCA RATON, Fla., May 4, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results for the three months […]
Sensus Healthcare to Host First Quarter 2017 Financial Results and Business Update Conference Call on May 4, 2017
BOCA RATON, Fla., April 27, 2017 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids, with superficial radiation therapy (SRT), announced today that management will hold a conference call beginning at 4:30 p.m. Eastern Time on Thursday, May 4, 2017 to discuss the […]